Search results
Author(s):
Basel Ramlawi
,
Mahesh Ramchandani
,
Michael J Reardon
Added:
3 years ago
Symptomatic severe aortic stenosis or insufficiency have no effective medical treatments and carry a dismal prognosis if left untreated. Since the first aortic valve replacement in 1960, hundreds of thousands of lives have been saved and improved by this procedure. Until recently, surgical aortic valve replacement (sAVR) was the only effective therapy for severe aortic valve stenosis. The recent…
View more
THV Summit
Author(s):
Darren Mylotte
,
Lars Søndergaard
,
Dr Won-Keun Kim
Start date:
Jul 01, 2022
Broadcast
Author(s):
Lars Søndergaard
,
Pablo Lamelas
,
Won Keun-Kim
,
et al
Start date:
Nov 12, 2020
View more
Pilar Jimenez-Quevedo
Research Area(s) / Expertise:
Author
Expertise
Author(s):
Nicolas M Van Mieghem
Start date:
Dec 08, 2015
During coronary revascularisation involving a main vessel and a side branch, it is unclear whether ballooning of the side branch is a prerequisite for long term clinical success. Coronary physiology techniques such as Fractional Flow Reserve (FFR) provide a unique way to scientifically quantify whether a side-branch may need revascularisation following treatment of the main vessel.
Frequently it…
View more
Nicolas M Van Mieghem
Research Area(s) / Expertise:
Author
Expertise
Michael J Mullen
Research Area(s) / Expertise:
Author
Expertise
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
1 year ago
In this short and engaging episode of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) share their take on the most impactful hot-line and late-breaking trials from ESC 2022.
Which trials should we look out for?
Trials covered in detail include:
TAILOR-PCI: Tailored Antiplatelet Therapy Following PCI
ASCEND: A Study of…
View more
Author(s):
Christian Besler
,
Christopher U Meduri
,
Philipp Lurz
Added:
3 years ago
Accumulating evidence suggests that tricuspid regurgitation (TR) is independently associated with reduced long-term survival in the community and patients with ischaemic or dilated cardiomyopathy.1 Patients with moderate-to-severe TR suffer symptoms of progressive right heart failure, which are often difficult to treat with diuretic therapy. Prevalence estimates based on data from the Framingham…
View more
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
1 year ago
What are the take-home messages from ESC 22 and what are the implications for practice?
In this short wrap-up video of ESC 22, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) review the most impactful hot line and late-breaking trials of ESC Congress 2022.
Trials covered in detail include:
On clinical judgement after PCI
00:35:27:REVIVED-BCIS2: Study of…
View more